AIM
ABBV icon

ARK Investment Management’s AbbVie ABBV Stock Holding History

ARK Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-546,411
Closed -$61.5M – 300
2021
Q2 		$61.5M Sell
546,411
-6,706
-1% -$755K 0.11% 114
2021
Q1 		$59.9M Buy
+553,117
New +$59.2M 0.12% 121

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ARK Investment Management's ABBV Position: Q3 2021 in Review

ARK Investment Management sold out of AbbVie (ABBV) in Q3 2021, closing a stake of 546,411 shares — an estimated $61.5M sold.

ARK Investment Management first reported a position in ABBV in Q1 2021 and held it in 2 quarters. The position peaked at $61.5M in Q2 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • ARK Investment Management reported no remaining AbbVie position as of Q3 2021 after selling out during the quarter.
  • ARK Investment Management sold 546,411 AbbVie shares in Q3 2021, an estimated $61.5M.
  • ARK Investment Management first reported a position in AbbVie in Q1 2021 and held it in 2 quarters.
  • ARK Investment Management's AbbVie position peaked at $61.5M in Q2 2021.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on ARK Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.